Portfolio (Quarterly)
Guide ↗
Lion Point Capital, LP
· CIK 0001643354| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | PRAXIS PRECISION MEDICINES I | — | 4,450.0 | $1.4M | 8.57% | — | — | $322.19 | — |
| 2 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 67,500.0 | $1.3M | 7.52% | — | — | $18.64 | -35.4% |
| 3 | RPRX | ROYALTY PHARMA PLC | Healthcare | 21,400.0 | $1.0M | 6.13% | — | — | $47.97 | +21.3% |
| 4 | MIST | MILESTONE PHARMACEUTICALS IN | Healthcare | 820,000.0 | $976K | 5.83% | +65K | +8.6% | $1.19 | -33.7% |
| 5 | GERN | GERON CORP | Healthcare | 578,000.0 | $861K | 5.15% | — | — | $1.49 | -15.4% |
| 6 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 36,000.0 | $841K | 5.03% | — | — | $23.36 | -22.1% |
| 7 | ARDX | ARDELYX INC | Healthcare | 128,650.0 | $771K | 4.61% | — | — | $5.99 | -42.9% |
| 8 | FENC | FENNEC PHARMACEUTICALS INC | Healthcare | 112,434.0 | $691K | 4.13% | — | — | $6.15 | +72.4% |
| 9 | — | BENITEC BIOPHARMA INC | — | 62,000.0 | $660K | 3.95% | — | — | $10.65 | — |
| 10 | SRPT | SAREPTA THERAPEUTICS INC | Healthcare | 28,500.0 | $620K | 3.71% | — | — | $21.76 | -14.2% |
| 11 | — | DISC MEDICINE INC | — | 8,100.0 | $518K | 3.10% | — | — | $63.94 | — |
| 12 | — | CUE BIOPHARMA INC | — | 2,202,854.0 | $506K | 3.03% | — | — | $0.23 | — |
| 13 | CMPS | COMPASS PATHWAYS PLC | Healthcare | 80,000.0 | $442K | 2.64% | +22K | +37.9% | $5.53 | +136.2% |
| 14 | — | BIOHAVEN LTD | — | 51,700.0 | $437K | 2.61% | — | — | $8.46 | — |
| 15 | LNTH | LANTHEUS HLDGS INC | Healthcare | 5,500.0 | $417K | 2.49% | — | — | $75.85 | +31.5% |
| 16 | — | JASPER THERAPEUTICS INC | — | 465,000.0 | $407K | 2.44% | — | — | $0.88 | — |
| 17 | HUMA | HUMACYTE INC | Healthcare | 650,000.0 | $394K | 2.36% | +150K | +30.0% | $0.61 | -8.1% |
| 18 | VTRS | VIATRIS INC | Healthcare | 27,700.0 | $374K | 2.24% | — | — | $13.51 | +32.0% |
| 19 | KURA | KURA ONCOLOGY INC | Healthcare | 46,000.0 | $374K | 2.23% | — | — | $8.13 | +32.3% |
| 20 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 5,000.0 | $371K | 2.22% | — | — | $74.26 | -11.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%